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Abstract 
Introduction: Fear of recurrence (FOR) has been studied in various populations of 
patients with cancer e.g. colon, prostate, and breast.  Breast cancer survivors are often faced with 
the lingering fear that the cancer may reoccur.  It is estimated over 232,000 women diagnosed 
with breast cancer in 2014 FOR has the possibility to impact the lives of thousands of women. 
Yet, little is known about FOR in women diagnosed with breast cancer at a young age and are 
young breast cancer survivors (YBCS). These cancer survivors need additional support, as the 
probability they will develop another cancer is high. 
Purpose:  The purposes of this study were to 1) describe FOR in a large, statewide sample 
of YBCS 2) to explore predictors of FOR and 3) to determine if FOR is a mediator for breast 
cancer surveillance, namely mammograms and clinical breast exams (CBE).  
Methods: This secondary data analysis examines baseline data collected for an efficacy 
trial, aiming to increase breast cancer surveillance and use of cancer genetic services among 
YBCS and their high risk family members. Fear of recurrence was examined in 863 YBCS 
identified and recruited through the Michigan cancer registry.  Participants completed a survey 
including instruments that measured FOR, quality of life (mental and physical), self-efficacy in 
managing breast cancer, perceived breast cancer risk, knowledge of breast cancer risk factors, 
family support, and current breast cancer surveillance practices. 
Findings:  Results of this study suggest predictors of FOR in young breast cancer 
survivors include African American race, lower level of education, belief that cancer 
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development is by chance, and increased level of anxiety. The strongest predictor of FOR was 
low level of self-efficacy in managing breast cancer.  Being negative for the BRCA1 genetic 
marker was found not to be associated with FOR in this population.  FOR did not mediate 
surveillance mammograms or clinical breast exams. 
Conclusion:  Knowing what predicts young breast cancer survivors to experience FOR is 
important in lessening FOR. Employing screening measures to determine patients at risk for 
experiencing FOR may lessen this problem
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Chapter 1  
Introduction 
The statistics regarding breast cancer occurrence, survival, and death are alarming. The 
American Cancer Society estimates 232, 670 women will be diagnosed with breast cancer and 
40,000 women will die of breast cancer in 2014 (American Cancer Society, 2014). The overall 
five year survival rate for breast cancer patients is 89.2% (Howlader et al., 2013). Currently, 
about 1 in 4 cancer survivors in the United States is a breast cancer survivor (Rowland & 
Bellizzi, 2008). Given these overwhelming figures it is important to understand what women 
with breast cancer find most problematic.  Fear of recurrence (FOR) is often at the top of the list.  
Lebel, Rosberger, Edgar, & Devins (2007) revealed of the four most common stressors breast 
cancer survivors face, FOR was deemed the most stressful. FOR has been identified as an unmet 
need among cancer survivors and their families (Baker, Denniston, Smith, & West, 2005; Lebel, 
Tomei, Feldstain, Beattie, & McCallum, 2013; Mellon & Northouse, 2001; Turner et al., 2013).   
While older studies have reported FOR as a concern in 89-94% of women with breast 
cancer (Polinsky, 1994), the research in this literature review report FOR an issue for 39%-70% 
of women studied (Baker et al., 2005; Befort & Klemp, 2011; Cappiello, Cunningham, Knobf, & 
Erdos, 2007; McGinty et al., 2012; Stanton, Ganz, Rowland, Meyerowitz, Krupnick, & Sears, 
2005; Stephens, Osowski, Fidale, & Spagnoli, 2008; Thewes et al., 2012; van den Beuken-van 
Everdingen et al., 2008).   
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Definition of Fear of Recurrence 
 
 FOR has been defined as fear of breast cancer coming back in the same breast or another 
area of the body, or a new breast cancer in either breast (Johnson Vickberg, 2003). Although the 
exact makeup of FOR is unknown, it has been suggested that it is a combination of emotion 
(fear) and cognition (threat), that is generated by internal (somatic) and external (e.g. 
conversations regarding cancer) cues (Custers et al., 2013). FOR  is multi-dimensional, 
encompassing emotional, physical, and spiritual realms of one’s life (Cannon, Darrington, Reed 
& Loberiza, 2011; Johnson Vickberg, 2003; Simard, Savard, & Ivers, 2010).   A systematic 
review reported that FOR was associated with poor quality of life (Sammarco & Konecny, 2008; 
van den Beuken-van Everdingen et al., 2008), decreased emotional wellbeing, increased anxiety, 
fatigue, and physical symptoms (Koch, Jansen, Brenner, & Arndt, 2012). FOR has also been 
shown to be a barrier to follow up care and surveillance (Thompson, Littles, Jacob, & Coker, 
2006).  Research has shown women with breast cancer adjust well physically to living with the 
disease (Stephens et al., 2008) but FOR can last for decades beyond the original diagnosis 
(Hodgkinson et al., 2007; Johnson Vickberg, 2003; Lebel et al., 2007; Ness et al., 2013).   
Purpose/Specific Aims 
 The purpose of this study, was 1) describe FOR in a large, statewide sample of YBCS to 
investigate what factors predict FOR in YBCS, 2) to determine who is at greatest risk of 
experiencing FOR, and 3) to determine if FOR has a mediating effect for breast cancer 
surveillance, namely mammograms and clinical breast exams (CBE) use.  It is hypothesized 
that FOR has a mediating effect on breast cancer surveillance. 
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Chapter 2  
Theoretical Framework and Literature Review 
 The Stress and Coping Theory (Lazarus & Folkman, 1984) was used as a theoretical 
model to guide this study and to organize findings from the literature into meaningful categories.  
Stress is defined as situations which exceed the person’s ability to cope (Lazarus & Folkman, 
1984).  Coping is defined by Lazarus and Folkman (1984) as thoughts and behaviors that people 
use to manage stressors. The Stress and Coping Theory posits that when faced with a stressor, 
e.g. disease, cognitive appraisal is used to determine if it is a threat to one’s well-being. If the 
person feels this threat is manageable problem-focused coping is used.  This may include 
information seeking, information sharing, and disease surveillance.  Conversely if the treat is 
perceived as beyond one’s ability to cope, emotion-focused coping may be used.  This may 
include avoidance and lead to a lack of follow-up and surveillance (Lazarus & Folkman, 1984). 
For this patient population stressors included triggers, symptoms, perceived risk, and a second 
cancer diagnosis.  All demographic information was categorized as antecedents. Factors that 
were included as coping resources were spirituality, religion, self-efficacy, and family support.   
A diagrammatic representation of the conceptual framework is found in Figure 1. 
 The method used to identify articles for this literature review included a keyword search, 
a forward citation search and a backward citation search.  Searches were conducted using three 
electronic databases, CINAHL, MEDLINE, and PsychINFO, limiting the dates of publication 
between 2000-2013.  Search terms included: breast cancer survivor, fear of recurrence, fear of 
cancer recurrence, worry about recurrence, and concern about recurrence. Articles were further 
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restricted to English language, female breast cancer patient, and presentation of empirical 
findings; qualitative or quantitative reports of data. This resulted in numerous articles and all 
duplicates were excluded.  This review covers 57 articles found to meet the above criteria as 
diagrammed in Figure 2.    
Factors Associated with FOR 
Demographics 
 Multiple studies have examined the relationship between patients’ demographic 
characteristics and level of  FOR (Bower et al., 2005; Costanzo et al., 2007;  Crane-Okada et al., 
2012; Komblith et al., 2007; Lebel et al., 2013; Mellon, Kershaw, Northouse, & Freeman-Gibb, 
2007; Johnson Vickberg, 2003; Mc Ginty et al., 2012; van den Beuken-van Everdingen et al., 
2008; Ziner et al., 2012)..  Younger age, most often defined as age 50 and younger, was 
associated with greater FOR in all studies included in this review.  A number of reasons have 
been postulated, including younger age is associated with higher levels of distress (Costanzo et 
al. 2007), younger survivors have less adaptation skills than older survivors (Komblith et al., 
2007), more aggressive breast cancers occur in younger women which leads to more aggressive 
treatment regimens (van den Beuken-van Everdingen et al., 2008), and breast cancer in this age 
group is “unexpected or off schedule” (Johnson Vickberg, 2003, p. 22).  Costanzo et al. (2007) 
suggested that younger women may experience greater FOR since they have not considered 
themselves at risk for developing a life threatening illness or have not had peers with serious 
health issues.  This explanation was also corroborated by research by Komblith et al. (2007) who 
found that younger women experienced greater FOR and attributed it to having less coping skills 
related to illness and the possibility of death.  FOR also has been found to impact treatment 
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decision making. Young women with breast cancer were found to overestimate their risk of 
developing cancer in the other breast and chose bilateral mastectomy.  The researchers explained 
that although the women understood removing the unaffected breast did not increase survival 
FOR impacted their decision (Rosenberg, et al. 2013). 
 Older survivors have fears of their cancer returning, but research has shown these fears 
were less bothersome when compared to the fears of younger breast cancer survivors (Yoo 
Levine, Aviv, Ewing, & Au, 2010).  Yoo and colleagues (2010) found older breast cancer 
survivors to be worried more about dependence on others than FOR.  Mellon et al., (2007) found 
age at time of diagnosis to impact both the cancer survivor and the caregiver, but in an opposite 
direction.  Survivors with younger caregivers were found to have greater FOR and caregivers 
with younger survivors had greater FOR (Mellon et al., 2007). FOR also influenced surveillance 
behavior; younger survivors were also seen to become hyper-vigilant in self-assessment, have 
more physician office or clinic visits, and use more healthcare resources than older survivors 
(Thewes et al., 2012). 
Ethnicity and Race 
According to the American Cancer Society (2014) fewer African American women 
develop breast cancer compared to Caucasian women; however, African American women are 
more likely to die from breast cancer than their Caucasian counterparts. Reasons for this 
disparity include African American women are often diagnosed at a later stage of cancer when it 
is less likely to respond to treatment and they often have greater co-morbidities.  Other variables 
for this disparity include less access to medical care and less cultural and social support (Bibb, 
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2001).  The difference in incidence of breast cancer among the races has led to studies to 
determine how FOR impacts women of different races and ethnicities. 
Ethnicity and race have also been studied and were linked to FOR in breast cancer 
survivors.  Researchers have compared the level of FOR reported by Caucasian women and 
women from other races or ethnicities. (Befort & Klemp, 2011; Deimling, Bowman, Sterns, 
Wagner, & Kahana, 2006; Gil et al., 2004; Janz et al., 2011; Johnson Vickberg, 2001; Katz et al., 
2010; Kelly, Shedlosky-Shoemaker, Porter, Desimone, and Andrykowski, 2011; Russell, Von 
Ah, Gielser, Storniolo, & Haase, 2008). They found that Caucasian women reported more FOR 
than their African American counterparts.  However, two studies including primarily African 
American women reported conflicting findings.  Deimling et al. (2006) and Russell et al. (2008) 
found that African American breast cancer survivors reported less FOR and less cancer worries.   
While reporting less FOR may be seen as a positive aspect, Deimling and colleagues 
(2006) suggest that survivors who experience less concern for developing a second cancer may 
be less diligent in self-monitoring or participating in follow up surveillance.  African American 
women were also found to have less perceived risk of recurrence when compared to Caucasian 
women and this perception may lead to less follow up surveillance (Liu et al., 2011).  An 
exploratory qualitative study of African American women showed FOR can be either a facilitator 
or a barrier to seeking follow up care (Thompson et al., 2006).  For some women, FOR 
motivated them to participate in follow up care in order to be observant for symptoms of 
recurrent disease.  Conversely, other women in the same study found FOR to be a barrier to 
follow up care as they were afraid of the possibility of another cancer diagnosis (Thompson et 
al., 2006). 
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Studies of Latina breast cancer survivors have also examined their experience with FOR 
(Janz, 2011; Sammaro & Konecny, 2008).  Janz and colleagues (2011) studied African 
American, Caucasian, and Latina women and found significant differences. Forty six percent of 
low acculturated Latinas reported the highest level of FOR, compared with 25% of high 
acculturated Latinas, 14% of Caucasians, and 13% of African American survivors (Janz et al., 
2011).  Janz and colleagues (2011) believed these differences in FOR to be related to difficulty 
in communication, ease of understanding information, and coordination of care programs.  A 
study of women living in the Appalachian region of the United States found these women also 
report high levels of FOR.  This was thought to be secondary to lack of health education 
resources and health care facilities (Kelly, et al. 2011).   Johnson Vickberg (2003) suggests that 
Latina women may perceive recurrence as more severe and may have increased worry about the 
end result of a recurrent tumor and subsequent treatment. Understanding the difference in FOR 
experiences among women of different races and ethnicities helps to build a foundation for 
culturally competent care. 
Education Level 
 The education level of breast cancer survivors has also been studied to determine if there 
is an impact on the level of FOR.  The findings have been mixed.  In a study of 203 breast cancer 
survivors, Clayton and colleagues found education to be inversely related to FOR; lower 
educated women had higher levels of FOR (Clayton, Mishel, & Belyea, 2006).   The authors 
suggest women with higher education may be better equipped to sort out the facts versus the 
myths regarding breast cancer recurrence (Clayton et al., 2006).  This finding was corroborated 
by research done by Ashing-Giwa and colleagues (2011) who found women with less education 
to have greater FOR. Janz and colleagues (2011) studied 2290 women and found similar results; 
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an inverse relationship between education and FOR. Conversely, Costanzo et al. (2007) found 
women who had more than 12 years of education but less than a college degree had the highest 
levels of FOR. The authors postulate that perhaps women who have higher level of education are 
better able to utilize medical information or communicate better with healthcare practitioners, 
although it was unclear why women with less education have overall less FOR (Costanzo et al. 
2007). Finally, a study of 136 women, reported that their higher education level was associated 
with increased health and role worries due to an increase in triggers of FOR (van den Beuken-
van Everdingen, et al., 2008).  
Urban versus Rural Dwelling Women 
 Women of geographically identified groups have also been studied.  Rural women make 
up one of the largest medically underserved groups in the United States (Befort & Klemp, 2011). 
However, insufficient research has been done regarding their needs compared to urban women 
(Katz et al., 2010). The Appalachian women of Ohio (Katz et al., 2010) and women living in 
rural areas of Kansas (Befort & Klemp, 2011) were studied to determine how FOR impacts their 
breast cancer survivorship.  Katz and colleagues (2010) found that Appalachian Ohio breast 
cancer survivors had less overall concerns than their urban counterparts; however the most 
common worry of both the urban and rural women was FOR. Beyond FOR, the concerns of rural 
women centered on difficulty finding and understanding cancer related information.  These 
women also reported more concerns with paying medical bills, health insurance issues, and the 
need for support groups than their urban counterparts (Katz et al., 2010).  The concerns of urban 
women that were not seen in the rural population were related to diet and herbal supplements and 
relaxation techniques (Katz et al., 2010).  
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In order to determine if the psychosocial needs of rural breast cancer survivors differed 
from their urban counterparts, Befort and Klemp (2011) studied breast cancer survivors in 
Kansas.  The women were separated into categories based on the geographic location where they 
lived.  The authors found 68% of women who were premenopausal at time of diagnosis were 
troubled with FOR compared to 47% of women who were postmenopausal at diagnosis (Befort 
& Klemp, 2011).  This is in-keeping with other studies which found women of younger age more 
bothered with FOR (Costanzo et al., 2007;  Crane-Okada et al. 2012; Komblith et al., 2007; 
Johnson Vickberg, 2003;  Lebel et al., 2013; Mellon et al., 2007; Mc Ginty et al., 2012; van den 
Beuken-van Everdingen et al., 2008; Ziner et al., 2012). This also supports other studies which 
have shown that women who live in rural areas are more prone to FOR because these women 
often have greater numbers of mastectomies and adjuvant chemotherapy, both have been shown 
to increase rates of FOR (Constanso et al., 2007). Also women in rural areas have less social 
support which also leads to greater FOR (Bettencourt, Schlegel, Talley, & Molix, 2007).  
Treatment type and FOR 
 The type of treatment received has also been examined to determine its effect on a 
survivor’s FOR. The severity of the disease was not found to be correlated with the amount of 
worry experienced by 406 breast cancer survivors (Mathews, Ridgeway, Warren, & Britton, 
2002).  However, type of surgery was associated with FOR. Women with a mastectomy were 
found to have less FOR than women who elected to have lumpectomy (Costanzo et al., 2007; 
Janz et al., 2005), possibly because survivors who had a mastectomy thought that more extensive 
surgery would get rid of the cancer (Costanzo et al., 2007). Women whose cancer was diagnosed 
as ductal carcinoma in-situ (DCIS) were found to overestimate their risk of recurrence (Liu, et al. 
2010).  This confusion was thought to be due to the similarity of treatment methodology for 
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DCIS and stage I breast cancer (Liu, et al., 2010).  Survivors also reported FOR related to the 
chemotherapy and/or radiation treatments causing a second cancer (Deimling, et al., 2006). 
Some research indicates that FOR is higher in women who have had chemotherapy 
(Costanzo et al., 2007; Janz et al., 2005; Johnson Vickberg, 2003). Johnson Vickberg (2001) 
found survivors who had previous chemotherapy feared the need for future chemotherapy as 
much as death. Costanzo et al. (2007) contends that this fear may be due to the side effects 
associated with chemotherapy and the fact that women who undergo chemotherapy may have 
more severe disease. This finding was especially true among young cancer survivors who 
commonly have more aggressive cancer requiring more aggressive treatment.   The stage of the 
disease was not seen as contributing to FOR (Taylor et al., 2012; Thewes, Bell, & Butow, 2013; 
Johnson Vickberg, 2003).  According to Johnson Vickberg (2003) FOR is influenced by factors 
beyond the stage of the disease, but more research is needed to discern what those factors may 
be.  
Radiation therapy was also found to be a variable in FOR experience of breast cancer 
survivors (Janz et al., 2011; Liu, et al. 2010). Women who received radiation therapy following 
breast conserving surgery were found to underestimate their risk of recurrence (Liu et al., 2010).  
The authors surmised this may be due to the fact the women believed they had less severe 
disease and therefore were at lower chance for recurrence (Liu et al., 2010).  
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Time Since Diagnosis 
 The time since diagnosis and the level of FOR was studied and the findings are 
contradictory.  Gil and colleagues (2004) and van den Beuken-vanEverdingen and colleagues 
(2008) found that time since diagnosis had no bearing on FOR.  In contrast, Deimling et al. 
(2006) in a study of breast cancer survivors greater than 50 years old and more than 5 years since 
original diagnosis found as time from diagnosis increases the level of FOR decreases.  
Triggers of FOR 
 FOR is often triggered by internal or external cues.  In regard to internal cues, three 
studies reported that physical symptoms trigger increased FOR. For example, physical symptoms 
such as joint stiffness, pain, and fatigue were found to bring about intrusive thoughts of fear the 
cancer had returned (Clayton et al., 2006; Gil et al., 2004; Johnson Vickberg, 2001). However, 
physical symptoms such as numbness and tingling were not related to higher levels of FOR in a 
large study conducted by Ziner and colleagues (2012).  Educating women to differentiate 
between everyday aches and pains from those symptomatic of breast cancer recurrence would be 
helpful to decrease FOR (Corder, Findlay, Broom, & Petrie, 2013).   
There are also external cues that can trigger FOR.  Among the external cue reported in 
the literature that can increase FOR are follow up doctor appointments (Johnson Vickberg, 2001, 
Mathews, et al., 2002), repeated blood work and mammograms (Ziner et al., 2012), and planning 
future oriented activities (Johnson Vickberg, 2001).  In addition, hearing of someone else being 
diagnosed with cancer or recurrent disease was found to be a trigger of FOR (Gil et al., (2004); 
Johnson Vickberg, (2001). In contrast however, Ziner and colleagues (2012) did not find 
knowing someone with cancer to be a trigger of FOR when assessed in their large study (N= 
 
 
12 
 
1,228 women).  This study was primarily of younger women who may not know someone else 
with breast cancer. 
Religion and Spirituality 
 Spirituality and religion have an impact on the concerns about cancer recurrence.  A 
study of 551 predominately Caucasian survivors reported that 59% of the participants had FOR; 
however, those survivors who deemed themselves as highly spiritual had less FOR over the 
cancer trajectory (Cannon et al., 2011).   Similarly, in an exploratory study with 130 breast 
cancer survivors, Schreiber (2011) found that belief in God’s presence in one’s life was 
associated with lower FOR.  Coping via religion was also found to reduce FOR in a longitudinal 
study of 80 breast cancer survivors (Stanton, Danoff-Burg, & Huggins, 2002).  Following the 
teachings of the Islamic faith, Iranian women believe that cancer is the will of God (Fasihi 
Harandy et al, 2010).  Although they readily accept this as part of their religious beliefs, their 
faith was found to help them accept their diagnosis and hope for a cure (Fasishi Harandy et al., 
2010).  These women relied on prayer to help combat FOR. A study of African American 
women found they turned to the use of prayer to help them cope with the FOR (Thompson et al., 
2006). This finding was also seen in a study by Ashing-Giwa (2004) which revealed African 
American women relied on their religious beliefs to help them deal with their FOR.   
FOR and the Family 
 The survivor is not the only person for whom FOR is an issue.  Several studies have been 
done which show FOR is an issue for family members and caregivers as well (Kim, Carver, 
Spillers, Love-Ghaffari, & Kaw, 2012; Mellon et al., 2007; Mellon & Northouse, 2001).  Cancer 
severity and caregiver FOR was found to be highly correlated.  Kim et al., (2012) found 
 
 
13 
 
caregivers experienced greater FOR than the survivors as long as 2 years post diagnosis and that 
the caregiver’s FOR was directly related to the survivor’s physical health.  In a study of 246 pairs 
consisting of a survivor and a family caregiver, Mellon and colleagues (2007) found a 
relationship between the level of family stressors and meaning of illness impacted FOR. Those 
families who reported high family stress and less meaning of illness were found to have higher 
levels of FOR. It is important to note that in this study, family members reported greater FOR 
than did the survivors (Mellon, et al., 2007). Mellon and Northouse (2001) found family FOR 
directly impacted family quality of life and that survivor FOR affected family members meaning 
of the illness (appraisal as the illness as threatening).  This study looked at the relationship 
between the dyad of the survivor and the family member. Each individual person’s perception of 
the meaning of the illness rather than that of the partner (survivor or family) had more influence 
on FOR.  As one member’s FOR increased so did the other’s (Mellon & Northouse, 2001). 
Conclusion 
 Since FOR has such a large and potentially devastating impact on breast cancer survivors 
it is imperative that healthcare practitioners do an assessment to screen a woman to predict her 
risk for FOR.  The literature is replete with studies of women of various ages and their 
experiences with FOR but little is known regarding what predicts FOR in young breast cancer 
survivors.  Knowing what factors predict a young woman to be at risk for fear of recurrence is an 
important first step in understanding how healthcare practitioners can work with their patients to 
help them overcome the fear associated with their diagnosis. 
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Chapter 3  
Methods 
To examine the reported level of FOR in young breast cancer survivors (YBCS) and 
impact on breast cancer surveillance, a secondary analysis of data gathered from an earlier study 
was used.  In the parent study the Michigan Cancer Surveillance Program database was queried 
to recruit YBCS and their high risk female relative in an efficacy trial (Katapodi, et al., 2013).  
The Michigan Cancer Surveillance Program was enacted by law in 1984 to be a repository for 
reporting cases of in situ and invasive cancers in Michigan residents (Michigan Department of 
Community Health, 1978). 
Participants 
 A sample of 3,000 YBCS, stratified by race (Black vs. White/Other) was randomly 
selected from the Michigan Cancer Registry and was sent up to three invitation letters and the 
baseline survey (Katapodi et al. 2013). The 859 YBCS of this study (response rate approximately 
33%) met the eligibility criteria of the parent study, which included being female between the 
ages of 25-64, and diagnosed with unilateral or bilateral invasive breast cancer between the ages 
of 20 and 45 years old.  Participants also had to be a Michigan resident at the time of diagnosis, 
be able to read and understand English, and not be currently pregnant, incarcerated, or 
institutionalized (Katapodi, et al. 2013). For further details about study selection and recruitment 
methods see Katapodi et al. 2013. 
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 All data for this secondary data analysis were de-identified to ensure anonymity of study 
participants.  The secondary data analysis protocol was reviewed by the University of Michigan 
Institutional Review Board and an exempt status was awarded. 
Instrument 
 A survey with multiple instruments was used to collect participants’ responses in the 
parent study.  The data used for this secondary data analysis focused on responses relevant to 
YBCS FOR, quality of life (QOL), self-efficacy to manage breast cancer, family support, and 
breast cancer surveillance practices.   
 Four items from the Concerns About Recurrence Scale (CARS) were used to measure 
FOR.  The CARS was developed specifically to measure FOR in breast cancer survivors and has 
been found to have high internal consistency with a reported Cronbach’s alpha 0.87(Johnson 
Vickberg, 2003). It has also been found to have good construct validity (van den Beuken-van 
Everdingen et al. 2008). The four questions utilized a 7-point Likert scale to assess  the amount 
of time spent thinking about the cancer coming back, how often participants worry about the 
cancer coming back,  how much does thinking that breast cancer may come back upsets 
participants, and how afraid they are  that their cancer may come back.  See Table 3.1. 
 An updated version of the Breast Cancer Risk Factor Knowledge Index (Katapodi & 
Aouizerat, 2005) was used to measure participants’ knowledge of the risk factors associated with 
breast cancer.  This instrument has been used previously and had high internal consistency with 
Chronbach’s alpha .80 (Katapodi & Aouizerat, 2005).  The updated version of the index includes 
17 items that assess women’s knowledge of breast cancer risk factors; possible answers include 
true, false, or don’t know. See Table 3.2. 
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 Barriers and facilitators to mammography screening were assessed with the Decisional 
Balance Scale for Mammography (Rakowski et al., 1997).  The instrument has been used to 
predict mammogram use and measures the pros and cons of having a mammogram. See Table 
3.3. 
 Family support for breast cancer screening was measured using the Social Support for 
Breast Cancer Screening instrument.  This tool uses a 7 point Likert scale (1=never true, 
7=always true) to assess how the participant views the helpfulness of the people in her family 
relative to being overall supportive and family support in illness (Katapodi, Facione, Miaskowsi, 
Dodd, & Waters, 2002). See Table 3.4. 
 Participants’ self-efficacy to manage breast cancer was assessed on a 7-point Likert scale 
with 14 items developed for the parent study See Table 3.5. 
 Quality of life (QOL) was measured with SF-12 which measures physical component 
summary (PCS) and mental component summary (MCS).  The psychometric properties have 
been determined previously with reliability Cronbach co-efficient alpha 0.89 for PCS and 0.76 
for MCS (Ware, Kosinski, & Keller, 1996).  See Table 3.6. 
 Perceived risk was measured by asking one question which asked what they believed was 
their chance of getting another cancer.  Women answered the question on a 10 point Likert scale 
from 0=Definitely will not to 10=Definitely will (Katapodi, et al. 2011, Katapodi, Dodd, Lee, & 
Facione, 2009). 
 Demographic data were collected regarding personal information and health history.  
Items included age, ethnicity, race, type of cancer diagnosis, type of cancer treatment, level of 
education, health insurance status, and employment status.   
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Statistical analyses 
 Analyses were run using Statistical Package for Social Sciences (SPSS) version 21. 
Descriptive statistics were done to organize the demographic data into meaningful groups.  
Frequency statistics were done to determine the distribution of scores for reported level of fear of 
recurrence.  Pearson’s product moment correlations were done to examine associations between 
the dependent variables of FOR, frequency of CBE, and frequency of mammography,  and  the 
independent variables of age, race, education, income, insurance status, routine source of care, 
lack of access to care due to cost, years since diagnosis, perceived risk, self-efficacy, family 
support, family support in illness, confidence in CBE, confidence in mammogram, and QOL. 
 Multiple regression analyses explored predictors of FOR and whether FOR is a mediator 
for frequency of CBE and frequency of mammography. See Figure 3. Variables which act as 
mediators provide additional information regarding how two variables are strongly associated 
(Bennett, 2000).  In this study it was important to understand if FOR mediated surveillance use 
of mammogram or CBE.  In order to test this step-wise regression was used.  
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Chapter 4  
Findings 
 The study population was made up of 859 female breast cancer survivors aged 45-57 
(mean age 51 ±6).  Time since diagnosis ranged from seven to 15 years (mean time since 
diagnosis 11±4).   
 The racial make-up of the participants was categorized as white/other or black.  This is in 
keeping with the method of data stratification in the parent study.  Overall the greatest number of 
participants self-identified as white N=488 with 24 participants reporting as other e.g. American 
Indian, Arab-American, Asian.  There were 313 participants who self-identified as black.  The 
racial information of the study population is found in Table 4.1. 
 The current marital status for the white/other population was predominately married 
(n=376, 72.7%), whereas the black participants were less likely to be married (n=112, 33.1%)   
X² (4, n = 854) = 165.29, p < .000.  A complete breakdown of marital status data is found in 
Table 4.1. 
 The majority of study participants were employed full time, white/other n=274 (55.1%), 
black n=150 (45.5%).  The most common job description was executive, managerial, or 
professional, whites/other n=194 (39.8%), blacks n=94 (30.1%).  A large disparity was noted in 
income with the largest number of whites/others earning $120,000 or greater (n=94, 18.5%) 
compared to Blacks (n= 20, 6.1%) whereas the greatest number of blacks (n=90, 27.4%) reported 
earning less than $20,000.  Complete data is found in Table 4.1. 
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 The highest level of education was similar for all participants.  The white/other 
participants n=197 (38.4%) attended college but did not obtain a degree.  Similarly, 125 (37.2%) 
of black participants also attended college but did not obtain a degree. A difference was seen in 
the participants who completed college, whites/others n= 130 (25%) compared to black n= 60 
(17%).  Both categories of study participants had 2 members who attended school only through 
the eighth grade, white/other n=2 (0.4%), black n=2 (0.6%). The educational information for the 
complete study population is found in Table 4.2. 
 The type of cancer the participants (N=816) reported was nearly evenly distributed.  
Invasive carcinoma was reported by 56.4% of the participants and ductal carcinoma in situ 
(DCIS) was reported by 53.3% of the participants. Further analysis by racial groups found 
white/other reported invasive breast cancer n=278 (54.6%) and n=299 (58.7%) reported DCIS; 
blacks reported n=182 (59.3%) invasive breast cancer and n=136 (44.3%) reported DCIS.  
 The most commonly reported type of surgery was lumpectomy, N=335 (39%), with 
white/other reporting n=197 (38%), and blacks n=138 (40.6%). The next most common reported 
surgical treatment was single mastectomy N=219 (25.5%), with white/other reporting n=128 
(24.7%), and blacks n=91 (26.8%).  The totals of types of cancer diagnosis and types of surgical 
treatment percentages exceed 100%, because many YBCS had more than one surgery All cancer 
types and surgical treatments are listed in Table 4.3 
Distribution of FOR Scores 
 The FOR scores were measured on a Likert scale from 1 to 7.  In this sample of YBCS, 
the mean score of FOR was 3.46 ± 1.77.  One half of the participants’ reported FOR score was 
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below the midpoint (median score 3.25) indicating that as a whole this group was not very 
fearful of cancer recurring. Distribution scores are shown in Table 4.4 
Correlations 
 The relationship between average FOR and the independent variables was investigated 
using Pearson product-moment correlation coefficient.  Preliminary analyses were preformed to 
ensure no violation of the assumptions of normality, linearity and homoscedasticity.  There were 
small negative correlations seen among FOR and age, education, income, lack of access to care 
due to cost, lack of  routine source of care, years since diagnosis, family support, and family 
support in illness, and depression.  The strongest negative correlation was found between FOR 
and self-efficacy to manage breast cancer.  A medium positive correlation was seen between 
FOR and perceived risk. The results are displayed in Table 4.5.  
Regression Analyses 
  The ability of the variables of race, education, income, marital status, insurance status, 
cost, years since diagnosis, perceived risk, depression, anxiety, self-efficacy, family support, 
family support in illness, and BRCA1 genetic status to predict FOR in YBCS was examined 
using linear multiple regression.  The overall model explained 35% of the variance in FOR (F 
[25, 561] = 12.10, p <.001; R=.59, Adj R² .35).  Six variables were statistically significant 
predictors of FOR: self-efficacy to manage breast cancer (b = -.256, p <.001), perceived risk (b = 
.241, p <.001), BRCA1 negative status (b = -.158, p <.001), anxiety (b = .144, p <.001), race (b = 
.139, p <.001, and education (b = -.081, p <.05). Results are displayed in Tables 4.6 and 4.7. 
Self-efficacy to manage breast cancer was the strongest predictor of FOR in this population.  
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In order to examine results for a possible mediation effect of FOR and surveillance 
mammogram and CBE use the frequency of these exams and correlation results were reviewed.  
The reported frequency of surveillance mammograms and CBE for this study sample 
demonstrated the majority of women received mammograms and CBE every 12 months, with 
more women receiving CBE than mammograms.  See Table 4.8.  Since there was no correlation 
between FOR and frequency of mammography(r = .027, p = .444), a mediation between FOR 
and frequency of mammography was not possible. However, because there was a correlation 
between FOR and frequency of CBE (r=.104, p=.003), a stepwise regression analysis was done 
to test if FOR mediated frequency of CBE. In the first step all independent variables were 
entered into the model, while FOR was entered in the second step.  The initial step explained 
18% of the variance in the frequency of CBE (F [27, 509] = 4.21, p <.001; R=.438,  R² 18%,). A 
small mediation effect with a 1% difference from the first step was seen in step 2 (F [28, 508] = 
4.34, p <.001; R=.440, R² 19%,).  See Table 4.9.  Significant predictors of frequency of CBE 
were insurance status (b =.117, p <.05), access to routine source of care (b = .109, p <.05), and 
intention to have CBE (b = .088, p <.05).  See Table 4.10. 
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Chapter 5  
Discussion 
Breast cancer will be diagnosed in over 200,000 women in the United States this year  
and FOR will be an issue for many.  This study set out to investigate what factors predict FOR in 
YBCS, determine who is at greatest risk for experiencing FOR, and also to determine if FOR has 
a mediating effect for breast cancer surveillance mammograms and CBE.   
Being able to identify predictors of FOR in YBCS will be important to aid healthcare 
practitioners to recognize who is at risk for increased fears and possible decreased quality of life.  
Aim one of the study sought investigate factors which predict FOR in YBCS.  These factors will 
be discussed below. 
 Results of this study found younger age was associated with increased FOR.  The inverse 
relationship between younger age and increased level of FOR seen in this study is in-keeping 
with results of previous studies (Costanzo et al., 2007, Johnson Vickberg, 2003, Komblith et al., 
2007; van den Beuken-van Everdingen et al., 2008).  Stanton and colleagues (2002) suggest the 
increase in FOR in YBCS could be related to competing role responsibilities and the unexpected 
diagnosis in young women. Younger women often have more aggressive types of breast cancer 
which has been postulated to increase FOR (van den Beuken-van Everdingen et al., 2008). This 
study did not collect the type or stage of cancer in the participants so this association could not 
be studied.  
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 Black women reported more FOR than white/others in this study.  This differs from other 
studies which have reported African American women have less FOR than Caucasians (Befort 
and Klemp, 2011; Deimling et al., 2006, Gil et al. 2004; Janz et al., 2011; Johnson Vickberg, 
2001; Katz et al., 2010; Kelly, Shedlosky-Shoemaker, Porter, Desimone, & Andrykowski, 2011; 
Russell, Von Ah, Gielser, Storniolo, & Haase, 2008).  Two variables which may explain this 
finding are; this study was specific to YBCS whereas the reports in the literature were not, and 
also women in this study were on average 11 years post diagnosis it may be possible that the 
reported level of FOR in some women was decreased.   
 Lower level of education was associated with FOR in this study population.  More 
women in this study had some college education but no degree, however, this level of education 
did not lessen their FOR. Research has shown this result to be consistent. Costanzo, et al., (2007) 
found women with greater than 12 years of education but without a degree had higher levels of 
FOR. Also women with this particular level of education may be more susceptible to triggers of 
FOR (van den Beuken-van Everdingen et al., 2008). Previous research by Clayton, Mishel, and 
Belyea (2006), Ashing-Giwa et al., (2011) and Janz et al., (2011) all found lower educated 
women had higher levels of FOR.   Although it is unknown why this may be true for this 
population of women, the suggestion by Clayton et al., (2006) that women with higher education 
maybe better equipped to sort out the facts versus myths regarding breast cancer recurrence may 
have merit.  
 The results of this study found a diverging relationship between time from diagnosis and 
FOR.  The less time from diagnosis the greater FOR reported.  The women in this study 
population had been diagnosed as long as 15 years (mean years 11+ 4) prior to completing the 
survey.  It is possible that this length of time had a bearing on the results.  As seen in research by 
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Deimling et al., (2006) once women reach five years from time of diagnosis FOR decreases. This 
is not entirely surprising as research has shown the definite risk of cancer recurrence decreases 
with time (American Cancer Society, 2014; Johnson Vickberg, 2003).  This finding is contrary to 
the research by Gil et al. (2004)  and van den Beuken-van Everdingen et al. (2008) which found 
time since diagnosis had no bearing on FOR.  The women in Gil et al. (2004) had a mean age of 
64 and were 5-9 years post diagnosis while the women in van den Beuken-vanEverdingen et al. 
(2008) study were greater than 60 years old and had a mean years since diagnosis of 10 years. 
The participants in both of these studies were older women compared to the women in the 
current and the mean time since diagnosis was less than in the current study which may have 
impacted the results.   
 Family support has been studied and has been shown to be very effective in helping both 
the cancer survivor and the family member to adapt to the stressors of the disease (Kim, Carver, 
Spillers, Love-Ghaffari, & Kaw, 2012; Mellon et al., 2007; Mellon and Northouse, 2001).  
Women in this study report not only low levels of overall family support in general but low 
levels of family support in illness.  Lack of family support may impact FOR for these women 
because without family support, family stressors increase and family QOL decreases (Mellon, et 
al., 2007).  It is unknown why these women had such low reported levels of family support.  This 
is an area that needs to be addressed early in the disease processes in order to assess and provide 
appropriate social support to both patient and family members. 
 The results of this study found the greatest predictor of FOR in YBCS was the reported 
low degree of self-efficacy in managing breast cancer.   According to Melchior, Buscher, 
Thorenz, Grochocka, Koch, & Watzke (2013) perceived self-efficacy has a large impact on one’s 
ability to cope with cancer because of its role in regulating one’s cognitions, behavior, and 
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coping strategies.    Further research by Kretitler, Peleg, Ehrenfeld (2007), Rottmann, Dalton, 
Chriestensen, Freideriksen, and Johnansen, (2010), and Luszczynska, Mohamed, and Schwarzer 
(2005) further supports this as their research found self-efficacy to be essential to coping with 
cancer. Breast cancer self-efficacy may provide a protective effect for young breast cancer 
survivors who have high perceived risk of recurrence (Ziner et al., 2012.)  For the results of this 
study, the lack of self-efficacy to manage breast cancer can be tied to a lack of coping 
mechanisms which leads to an increase in FOR.   As seen in the conceptual model (Figure 1) 
secondary appraisal leads to ability to cope.  If one cannot cope due to lack of self-efficacy in 
managing breast cancer one may not proceed with necessary medical care requirements e.g. 
mammograms or CBE.  The lack of self-efficacy in managing breast cancer reported in this study 
population puts these participants at risk for increase FOR and lack of medical follow up.  
 Women who reported a high level of perceived risk of developing breast cancer were 
found to also have increased reported FOR. Perceived risk can be equated with threat appraisal. 
This finding was also noted in research by McGinty, Goldenberg, and Jacobsen (2012) who 
found women who had elevated threat appraisal and low coping appraisal experienced higher 
level of FOR.  Coping appraisal was not measured in the current study.  McGinty, Goldenberg, 
and Jacobsen (2012) posit that the interaction between threat and coping appraisal predicts FOR.  
This interaction between threat and coping is in agreement with Lazarus Theory of Stress and 
Coping (1984) which guided this study. 
 BRCA1 status was found to be a variable which predicted FOR in this study sample.  
Participants who were negative for the BRCA1 mutation reported less FOR than their 
counterparts.  This result is consistent with prior research which found women who were positive 
for the BRCA1 genetic mutation reported high levels of FOR and sought aggressive surgical 
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treatment including prophylactic mastectomy (Graeser, et al. 2009; Meltcalfe et al, 2011; 
Hawley, et al. 2014).  Hawley and colleagues (2014) studied 2290 women newly diagnosed with 
breast cancer and the extent of worry they experienced at time of treatment decision making.  
Nearly 20% of the women who were positive for the BRCA1 genetic mutation considered 
contralateral prophylactic mastectomy.  This treatment decision was found to be significantly 
associated with greater reported FOR although the procedure is not shown to decrease the risk of 
recurrence (Hawley, et al. 2014).   It is not known if women in the current study chose 
prophylactic mastectomy as a treatment option. 
 Aim two of the study was to determine who is at greatest risk of experiencing FOR.  
Results of this study indicate less education, perceived risk of developing breast cancer, 
increased anxiety, low self-efficacy for managing breast cancer, positive BRCA1 genetic status, 
and African American race were all predictors of increased FOR.  These results, as discussed 
above, are congruent with results in other studies.  Understanding what predicted FOR in this 
study sample is important.  What is important to note about these 6 variables is that 3 of them are 
amenable to change.  While health care practitioners cannot change genetic status, race, or level 
of education; practices can be employed to lessen anxiety, increase self-efficacy to manage 
disease, and acknowledge perceived risk of developing breast cancer.  Methods to increase 
coping appraisal can help lessen anxiety (McGinty et al., 2012) and psychosocial treatment e.g. 
support groups can help to increase self-efficacy (Melchior, 2013).  With respect to perceived 
risk of developing breast cancer, practitioners should assess if the patient is experiencing 
appropriate risk.  Inordinately high perceived risk may lead to increased fear but it may also lead 
some women to be hyper vigilant in screening behaviors.  Lessening this fear may produce 
unwanted deterrent to surveillance mammograms and CBE.  
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Overall, the reports of FOR in the present sample of YBCS were lower than what has 
been found in previous studies (Baker, et al., 2005, Deimling et al., 2006, Stanton et al, 2006; 
van den Beuken-van Everdingen et al., 2008), however, this sample was limited to YBCS only.  
Therefore the results may not be generalizable to other breast cancer survivors.  
Clinical Implications 
 The clinical importance of assessing self-efficacy early in the breast cancer treatment 
time frame may lead to recognition by healthcare providers of patients who are at risk of FOR 
and special attention can be given to address this concern.  Also the importance of surveillance 
mammogram and CBE can be emphasized and monitored.  Additionally psychosocial 
interventions to foster self-efficacy to manage breast cancer such as support groups should be 
initiated at time of disease diagnosis and continue throughout treatment (Melchior et al., 2011).  
Additionally assessment of the woman’s knowledge of breast cancer treatment regimen and 
goals needs to be done early and repeated often to be certain she understands the importance of 
surveillance.  Education regarding breast cancer treatment, the importance of surveillance, and 
the risk of one developing a second cancer may increase self-efficacy in managing breast cancer 
and may decrease FOR. 
Limitations 
There are several limitations to note in this study.   This sample included YBCS from one 
Midwestern state.  Thus, the results of this study cannot be generalized beyond the current 
sample.  Demographics and results may be different in other geographic areas. Other limitations 
of this study include being a secondary analysis of a database. Although this was rich with 
information and had a large number of participants there were questions that the researcher 
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would have liked to ask but could not.  For example, it would have been interesting to know if 
the women made any changes to their health behavior after being diagnosed e.g. dietary changes, 
exercise, smoking, and if  these changes to improve their health status had any impact on their 
FOR.  Other questions of interest include, when does FOR begin, does the level of FOR vary 
throughout the disease, do women diagnosed with different stages of disease vary in their 
reported FOR?  An important question that remains unanswered by this and current research in 
the literature: Is there an inverse relationship between self-efficacy for managing breast cancer 
and FOR, meaning does FOR impact one’s self-efficacy for managing breast cancer or does self-
efficacy for managing breast cancer impact FOR?  This will be fuel for future research. 
Future Research 
Future research should include assessing coping strategies and if FOR changes over the 
duration of time from diagnosis through survivorship.  As life’s trials and tribulations change 
one’s coping mechanisms may change as well as one’s self-efficacy for managing breast cancer.  
This may impact one’s FOR.  Future research should also determine if the observations of this 
study hold true in other samples of cancer survivors including young women, breast cancers 
survivors with different stages and types of cancer, and women for whom a second cancer has 
already been diagnosed.  It will also be important to determine if any interventions can be 
developed which impact the modifiable variables which lead to FOR. 
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Table 3.1 
Fear of Recurrence Questions 
How much time do you spend thinking that 
your breast cancer could come back? 
Not at all                                                      All the time 
1 2 3 4 5 6 7 
How often do you worry that your breast 
cancer could come back? 
Not at all                                                     A great deal 
1 2 3 4 5 6 7 
How often do you worry that your breast 
cancer could come back? 
Never                                                           All the time 
1 2 3 4 5 6 7 
How afraid are you that your breast cancer may 
come back? 
Not at all                                                    A great deal 
1 2 3 4 5 6 7 
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Table 3.2 
 
Breast Cancer Knowledge Index 
A woman’s risk for getting breast cancer is higher when she… True False Don’t know 
…had her first baby after she is 30 years old    
…had her first period before she is 12 years old    
…had her menopause after the age 50    
…is from Ashkenazi Jewish descent    
…had one or more breast biopsies    
…had breast cancer once before    
…has a family history of ovarian cancer    
…has a family history of breast cancer from the dad’s side of 
the family 
   
…has a relative who has had both breast and ovarian cancer    
…has a relative with breast cancer in both breasts    
…has a relative diagnosed with breast cancer younger than 50 
years old 
   
…has a male relative who had breast cancer    
…has multiple relative with breast cancer    
…has breast and ovarian cancer in the same side of the family    
…has a genetic mutation in the BRCA1 or BRCA2 genes    
…gets older    
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Table 3.3 
 
Barriers and Facilitators to Use of Mammography 
 Strongly 
disagree 
Disagree Somewhat 
Disagree 
Neutral Somewhat 
Agree 
Agree Strongly 
Agree 
I am more likely to go for 
mammograms if my doctor 
tells me it is important. 
1 2 3 4 5 6 7 
Mammograms are the best 
way to find breast cancer early 
1 2 3 4    5 6 7 
Having mammograms every 
year or two gives me a feeling 
of control over my health 
1 2 3 4 5 6 7 
Having mammograms every 
year or two give me peace of 
mind 
1 2 3 4 5 6 7 
Having mammograms causes 
me a lot of worry about 
possibly finding cancer 
1 2 3 4 5 6 7 
Having a mammogram is just 
looking for trouble 
1 2 3 4 5 6 7 
The cost of mammograms 
causes me to think twice about 
getting one 
1 2 3 4 5 6 7 
It is very hard for me to get to 
a place where they do 
mammograms 
1 2 3 4 5 6 7 
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Table 3.4 
Family Support 
The people in my family… Never  
True 
Almost 
Never  
True 
Seldom 
True 
Some- 
Times 
True 
Often 
True 
Almost 
Always 
True 
Always 
True 
Are willing to listen to me when 
I just need to talk 
1 2 3 4 5 6 7 
Give me a great deal of 
affection and warmth 
1 2 3 4 5 6 7 
Ignore or make light of my 
concerns 
1 2 3 4 5 6 7 
Support me as I try to cope with 
problems in my life 
1 2 3 4 5 6 7 
Change the topic when I discuss 
my concerns 
1 2 3 4 5 6 7 
Work as a team to manage 
concerns we have 
1 2 3 4 5 6 7 
Give me positive feedback for 
my attempts to cope with 
problems that I have 
1 2 3 4 5 6 7 
Offer to help me do things that 
are difficult for me to do 
1 2 3 4 5 6 7 
Do not like to talk about 
problems and concerns 
1 2 3 4 5 6 7 
Avoid talking about negative 
feelings and sad events 
1 2 3 4 5 6 7 
Disagree on how to solve 
problems we have 
1 2 3 4 5 6 7 
Hide their true feelings from 
each other 
1 2 3 4 5 6 7 
Make me feel comfortable 
when discussing my concerns 
1 2 3 4 5 6 7 
Make me feel that talking about 
my problems creates a lot of 
tension among us 
1 2 3 4 5 6 7 
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Table 3.5 
 
Family Support in Illness 
In our family, when I have a 
health problem… 
Never  
True 
Almost 
Never  
True 
Seldom 
True 
Some- 
Times 
True 
Often 
True 
Almost 
Always 
True 
Always 
True 
I have someone I can turn to 1 2 3 4 5 6 7 
I could easily find someone to 
help me with my daily work 
1 2 3 4 5 6 7 
There is at least one person 
whose advise I really trust 
1 2 3 4 5 6 7 
There is not one to turn to 1 2 3 4 5 6 7 
I can find someone to help me 
get to the doctor 
1 2 3 4 5 6 7 
I can talk to someone about my 
concerns and fears 
1 2 3 4 5 6 7 
There is someone helping me 
get the care that I need 
1 2 3 4 5 6 7 
I can get help with costs and 
expenses 
1 2 3 4 5 6 7 
There is no one to help me get 
the information that I need 
1 2 3 4 5 6 7 
I don’t have anyone I can 
confide in 
1 2 3 4 5 6 7 
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Table 3.6 
 
Self-Efficacy Scale 
Since my breast cancer 
diagnosis, I am able to… 
Strongly 
Disagree 
Disagree Some-
what 
Disagree 
Neutral Some-
what 
Agree 
Agree Strongly 
Agree 
Ask for help when I 
have problems related to 
my cancer 
1 2 3 4 5 6 7 
Deal with the fact that I 
had breast cancer 
1 2 3 4 5 6 7 
Deal the physical 
symptoms related to my 
cancer without feeling 
guilty 
1 2 3 4 5 6 7 
Handle any fears I have 
about the possibility of 
my cancer coming back 
1 2 3 4 5 6 7 
Handle life situations 1 2 3 4 5 6 7 
Do the things that are 
important to me 
1 2 3 4 5 6 7 
Have a productive life 1 2 3 4 5 6 7 
Enjoy leisure activities 1 2 3 4 5 6 7 
Work toward my 
personal goals 
1 2 3 4 5 6 7 
Deal with my emotions 1 2 3 4 5 6 7 
Identify changes in my 
body that may be related 
to my cancer coming 
back 
1 2 3 4 5 6 7 
Talk with my provider 
about symptoms that 
may be related to my 
cancer coming back 
1 2 3 4 5 6 7 
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Table 3.7 
 
Quality of Life 
 During the past 4 weeks have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health? 
 No Yes 
Accomplished less than you would like?                No Yes 
Were limited in your work or other activities?                No                                                          Yes
During the past 4 weeks have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (such as feeling depressed or 
anxious)? 
 No Yes 
Accomplished less than you would like?                No                                   Yes 
Didn’t do work or other activities as carefully as 
usual?                                                                           
               No                Yes 
 
How much of the time during the past 4 weeks…. 
All of the 
time  
Most of the 
time 
A good bit of 
the time 
Some of the 
time 
A little of the 
time 
None of the 
time 
Have you felt 
calm and 
peaceful? 
      
Did you have a 
lot of energy? 
      
Have you felt 
downhearted or 
blue? 
      
Have your 
physical health 
or emotional 
problems 
interfered with 
your social 
activities (like 
visiting friends, 
relatives, ect)? 
      
 No  Yes 
Have you ever been told by a doctor or a nurse that you had depression?   
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Table 4.1 
Sample characteristics  
 n % n % 
Mean age in years (SD, range) 51(+/-6, 45-57) 
Years since diagnosis (SD, 
range) 
11 (+/-4, 7-15) 
Race/Ethnicity* White/Other Black 
 488 95.3 313 92.9 
American Indian 12 2.3 10 3.0 
Arab-American 3 0.6 0 0 
Asian or Southeast Asian 8 1.6 3 0.9 
Hawaiian 0 0 1 0.3 
Prefer not to answer 10 2 11 3.3 
Marital Status     
Single 19 3.7 91 26.9 
Life Partner 17 3.3 10 3 
Divorced/Separated 91 17.6 104 30.6 
Widowed 12 2.3 20 5.9 
Other 2 0.4 1 0.3 
Employment     
Full-time 274 55.1 150 45.5 
Part-time 82 16.5 23 7.0 
Unemployed 22 4.4 33 10 
Homemaker 40 8.0 15 4.5 
Student 3 0.6 4 1.2 
Retired 31 6.2 37 11.2 
Unable to work 29 5.8 60 18.2 
Other 16 3.2 8 2.4 
Income     
Less than $20,000 40 7.9 90 27.4 
$20,000-$39,000 55 10.8 68 20.7 
$40,000-$59,000 79 15.6 57 17.3 
$60,000-$79,000 78 15.4 23 7 
$80,000-$99,000 46 9.1 20 6.1 
$100,000-$119,000 59 11.6 8 2.4 
$120,000 or greater 94 18.5 20 6.1 
Prefer not to answer 56 11.0 43 13.1 
*Total sums to greater than 100% because of multiple responses 
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Table 4.2 
Participant Education Level  
 White/Other Black 
n % n % 
Grades 1 through 8 2 0.4 2 0.6 
Grades 9 through 11 7 1.4 23 6.8 
High School Graduate/ GRE/Technical School 88 17.2 77 22.9 
Some College, no degree 197 38.4 125 37.2 
Completed College 130 25.3 60 17.9 
Postgraduate degree 89 17.3 49 14.6 
Total 513 100 336 100 
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Table 4.3 
Type of Breast Cancer Diagnosis and Surgery 
Cancer Diagnosis* White/Other Black 
 n % n % 
DCIS 299 58.7 136 44.3 
LCIS 25 4.9 7 2.3 
Atypical hyperplasia 10 2.0 2 0.7 
Breast Surgery*  
No Surgery 5 1.0 10 2.9 
Lumpectomy only 197 38.0 138 40.6 
Lumpectomy and Mastectomy 66 12.7 62 18.2 
Lumpectomy and Double 
Mastectomy 
61 11.8 15 4.4 
Mastectomy only 128 24.7 91 26.8 
Double Mastectomy 62 11.9 24 7.1 
*Total sums to greater than 100% because of multiple responses 
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Table 4.4 
Distribution of Average Fear Scores 
 
N=842 Missing=17 Mean=3.46 Median=3.25 SD=1.77 Min=1 Max=7 
     
Value Frequency Percent Cumulative 
Percent 
1.00 92 10.7 10.9 
1.25 23 2.7 13.7 
1.5 26 3.0 16.7 
1.67 1 0.1 16.9 
1.75 31 3.6 20.5 
2.00 82 9.7 30.3 
2.25 45 5.2 39.9 
2.75 23 2.7 42.6 
3.00 44 5.1 47.9 
3.25 39 4.5 52.5 
3.50 44 5.1 57.7 
3.75 19 2.2 60.0 
4.00 37 4.3 64.4 
4.25 29 3.4 67.8 
4.50 35 4.1 72.0 
5.00 36 79.3 79.3 
5.25 23 2.7 82.1 
5.50 25 2.9 85.0 
5.75 22 2.6 87.6 
6.00 27 3.1 90.9 
6.25 17 2.0 92.9 
6.33 1 0.1 93.0 
6.50 15 1.7 94.8 
6.75 8 1.0 95.7 
7.00 36 4.3 100.0 
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Table 4.5 
Pearson Product-Moment Correlations Between Meaningful Variables and Average Fear Score 
 
Scale Fear  
Fear - 
Age  -.179**            
Education   -.129**           
Income    -.089*          
Cost     .134**         
Routine 
care 
     -.095**        
Year since 
diagnosis 
      -.166**       
Perceived 
risk 
       .326**      
Self-
efficacy 
        -.387**     
Family 
support 
         -.165**    
Family 
support in 
illness 
          -.176**   
MCS12            -.079*  
Frequency 
of CBE 
            .104** 
 
*Correlation is significant at the 0.05 level (2-tailed) 
**Correlation is significant at the 0.01 level (2-tailed) 
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Table 4.6 
Regression Model Summary 
Model R R 
Square 
Adjusted 
R 
Square 
Std. Error 
of the 
Estimate 
Change Statistics 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
change 
1 .592 .350 .321 1.41957 .350 12.102 25 561 .000 
 
Predictors: (Constant), Misconceptions, Age, Education, Number of relatives with breast cancer, 
Anxiety, Marital Status, Insurance status, Multiple Cancer Diagnosis, Believe chance, Influence 
of others, BRCA status, Routine source of care, Barriers, Average self-efficacy, Average family 
support, Did not see doctor because of cost, Race status, Access, Depression, Benefits of 
Mammogram, Years since diagnosis, Mammogram unpleasant, Income, Susceptibility, Average 
family support in illness 
Dependent variable: Average fear 
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Table 4.7 
 
Regression Coefficient Results 
 
 
Constant Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. Correlations Collinearity 
Statistics 
B Std.error Beta Zero-order Partial Part Tolerance VIF 
Ave. self-
efficacy 
-.381 .060 -.256 -6.372 .000 -.365 -.260 -.217 .718 1.393 
Believe 
Chance 
.178 .026 .241 6.713 .000 .294 .273 .228 .896 1.116 
BRCA 
status 
-.654 .152 -.158 -4.292 .000 -.136 -.178 -.146 .853 1.172 
Anxiety .544 .166 .144 3.277 .001 .230 .137 .112 .599 1.670 
Race 
Status 
.500 .148 .139 3.372 .001 .088 .141 .115 .682 1.466 
Education -.132 .064 -.081 -2.068 .039 -.124 -.087 -.079 .754 1.324 
Worry 291 035 310 8.231 .000 .319 .328 .280 .818 1.223 
 
Dependent variable: average fear 
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Table 4.8 
 
Frequency of mammogram and CBE    
Mammogram Frequencies Total White/other Black 
Count Column 
N % 
Count Column 
N % 
Count Column 
N % 
> every 12 months 78 11.4% 36 9.2% 42 14.3% 
Every 12 months 541 79% 332 84.7% 209 71.3% 
Every 6 months 63 9.2% 23 5.9% 40 13.7% 
Every 3-4 months 3 0.4% 1 0.3% 2 0.7% 
Total 685 100% 392 100% 293 100% 
 
CBE Frequencies Total White/other Black 
Count Column 
N % 
Count Column 
N % 
Count Column 
N % 
> every 12 months 99 12.1% 61 125 38 11.9% 
Every 12 months 416 50.7% 261 52% 155 48.6% 
Every 6 months 22 27.5% 135 26.9% 91 28.5% 
Every 3-4 months 80 9.7% 45 9% 35 11% 
Total 821 100% 502 100% 319 100% 
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Table 4.9 
 
Results of Step-wise regression analysis to determine mediation effect FOR and CBE 
Model R R 
Square 
Adjusted 
R 
Square 
Std. Error 
of the 
Estimate 
Change Statistics 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
change 
1 .482 .183 .139 .72232 .183 4.217 27 509 .000 
2 .440 .193 .149 .71839 .010 6.587 1 508 .001 
 
Model 1 Predictors: (Constant) Confidence in CBE, Average family support, Years since 
diagnosis, Routine source of care, Believe chance, Multiple cancer diagnosis, Benefits of 
mammogram, Intent to CBE, Marital status, Number of relatives with breast cancer, Education, 
Anxiety, Worry about finding cancer, BRCA status, Did not see doctor due to cost, Unpleasant 
CBE, Average self-efficacy, Insurance status, Race status, Access, Depression, Influence of 
others, Misconceptions, Age, Income, Susceptibility, Average family support in illness. 
Model 2 Predictors: (Constant) Confidence in CBE, Average family support, Years since 
diagnosis, Routine source of care, Believe chance, Multiple cancer diagnosis, Benefits of 
mammogram, Intent to CBE, Marital status, Number of relatives with breast cancer, Education, 
Anxiety, Worry about finding cancer, BRCA status, Did not see doctor due to cost, Unpleasant 
CBE, Average self-efficacy, Insurance status, Race status, Access, Depression, Influence of 
others, Misconceptions, Age, Income, Susceptibility, Average family support in illness, Average 
fear. 
Dependent variable: Frequency of CBE 
 
 
 
48 
 
Table 4.10  
Predictors of CBE use  
Constant Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. Correlations Collinearity 
Statistics 
B Std.error Beta Zero-order Partial Part Tolerance VIF 
Insurance 
status 
.431 .177 .177 2.441 .015 .211 .108 .098 .702 1.425 
Routine 
source of care 
.438 .178 .109 2.453 .015 .174 .108 .098 .812 1.231 
Intention to 
have CBE 
.043 .021 .088 2.078 .038 .144 .092 .083 .886 1.129 
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